260 related articles for article (PubMed ID: 15693983)
1. Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness.
Brett S
Crit Care; 2005 Feb; 9(1):45-50. PubMed ID: 15693983
[TBL] [Abstract][Full Text] [Related]
2. Acid suppression therapy: where do we go from here?
Scarpignato C; Pelosini I; Di Mario F
Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
[TBL] [Abstract][Full Text] [Related]
3. Stress-related mucosal disease in the intensive care unit: an update on prophylaxis.
Sesler JM
AACN Adv Crit Care; 2007; 18(2):119-26; quiz 127-8. PubMed ID: 17473539
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
Huang JQ; Hunt RH
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists.
Barkun AN; Adam V; Martel M; Bardou M
Value Health; 2013; 16(1):14-22. PubMed ID: 23337211
[TBL] [Abstract][Full Text] [Related]
6. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
7. Achieving pH control in the critically ill patient: the role of continuous infusion of H2-receptor antagonists.
Moore JG
DICP; 1990 Nov; 24(11 Suppl):S28-30. PubMed ID: 1980180
[TBL] [Abstract][Full Text] [Related]
8. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
Geus WP
Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484
[TBL] [Abstract][Full Text] [Related]
9. Stress-related mucosal disease: risk factors and prophylactic therapy.
Spirt MJ
Clin Ther; 2004 Feb; 26(2):197-213. PubMed ID: 15038943
[TBL] [Abstract][Full Text] [Related]
10. When should stress ulcer prophylaxis be used in the ICU?
Quenot JP; Thiery N; Barbar S
Curr Opin Crit Care; 2009 Apr; 15(2):139-43. PubMed ID: 19578324
[TBL] [Abstract][Full Text] [Related]
11. Role of acid suppressants in prophylaxis of NSAID damage.
Chan FK; Sung JJ
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):433-45. PubMed ID: 11403537
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors and acid-related diseases.
Sachs G
Pharmacotherapy; 1997; 17(1):22-37. PubMed ID: 9017763
[TBL] [Abstract][Full Text] [Related]
13. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
Mazure PA
Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
[No Abstract] [Full Text] [Related]
14. Long-term acid control and proton pump inhibitors: interactions and safety issues in perspective.
Freston JW
Am J Gastroenterol; 1997 Apr; 92(4 Suppl):51S-55S; discussion 55S-57S. PubMed ID: 9127627
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal prophylaxis in critically ill patients.
Singh H; Houy TL; Singh N; Sekhon S
Crit Care Nurs Q; 2008; 31(4):291-301. PubMed ID: 18815475
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic approaches to reflux disease, focusing on acid secretion.
Kinoshita Y; Adachi K; Fujishiro H
J Gastroenterol; 2003 Mar; 38 Suppl 15():13-9. PubMed ID: 12698865
[TBL] [Abstract][Full Text] [Related]
17. Preventing the gastrointestinal consequences of stress-related mucosal disease.
Metz DC
Curr Med Res Opin; 2005 Jan; 21(1):11-8. PubMed ID: 15881471
[TBL] [Abstract][Full Text] [Related]
18. A review of stress-related mucosal disease.
Monnig AA; Prittie JE
J Vet Emerg Crit Care (San Antonio); 2011 Oct; 21(5):484-95. PubMed ID: 22316196
[TBL] [Abstract][Full Text] [Related]
19. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
[TBL] [Abstract][Full Text] [Related]
20. Controlling gastric pH: the impact of newer agents on the critically ill patient.
Earnest DL
DICP; 1990 Nov; 24(11 Suppl):S31-4. PubMed ID: 1980181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
